@article{6ec3ec4ed7cf4de9a64949083e7a25a8,
title = "Formation of lipofuscin-like autofluorescent granules in the retinal pigment epithelium requires lysosome dysfunction",
abstract = "PURPOSE. We aim to characterize the pathways required for autofluorescent granule (AFG) formation by RPE cells using cultured monolayers. METHODS. We fed RPE monolayers in culture with a single pulse of photoreceptor outer segments (POS). After 24 hours the cells started accumulating AFGs that were comparable to lipofuscin in vivo. Using this model, we used a variety of light and electron microscopical techniques, flow cytometry and Western blot to analyze the formation of AFGs. We also generated a mutant RPE line lacking cathepsin D by gene editing. RESULTS. AFGs seem to derive from incompletely digested POS-containing phagosomes and after 3 days are surrounded by a single membrane positive for lysosome markers. We show by various methods that lysosome-phagosome fusion is required for AFG formation, and that impairment of lysosomal pH or catalytic activity, particularly cathepsin D activity, enhances AF accumulation. CONCLUSIONS. We conclude that lysosomal dysfunction results in incomplete POS degradation and enhanced AFG accumulation.",
keywords = "Autofluorescent granules, Lipofuscin, Lysosome dysfunction, Photoreceptor outer segments, Retinal pigmented epithelium",
author = "Cristina Escrevente and Falc{\~a}o, {Ana S.} and Hall, {Michael J.} and Mafalda Lopes-Da-Silva and Pedro Antas and Mesquita, {Miguel M.} and Ferreira, {In{\^e}s S.} and {Helena Cardoso}, M. and Daniela Oliveira and Fradinho, {Ana C.} and Thomas Ciossek and Paul Nicklin and Futter, {Clare E.} and Sandra Tenreiro and Seabra, {Miguel C.}",
note = "Funding Information: Supported by Funda??o para a Ci{\^e}ncia e Tecnologia (FCT) ? Portugal co-funded by FEDER under the PT2020 Partnership Agreement (to MCS, including project PTDC/MED-PAT/30385/2017, iNOVA4Health-UIDB/04462/2020, research infrastructure PPBI-POCI-01-0145-FEDER-022122, M-ERA.NET 2/0005/2016), Boehringer Ingelheim (to MCS), Fight for Sight UK (to MCS), Wellcome Trust grant number 212216/Z/18/Z/ (to CEF). MJH was funded by Moor-fields Eye Charity with the Bill Brown 1989 Charitable Trust PhD studentship 538158, MLS was funded by FCT-CEECIND/01536/2018, ACF was funded by FCT PhD studentship (PD/BD/135503/2018). This work was developed with the support from the research infrastructure PPBI-POCI-01-0145-FEDER-022122, co-financed by FCT (Portugal) and Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund) and this article is supported by the LYSOCIL project funded by the European Union?s Horizon 2020 programme under grant agreement No. 811087. Funding Information: Supported by Funda{\c c}{\~a}o para a Ci{\^e}ncia e Tecnologia (FCT) – Portugal co-funded by FEDER under the PT2020 Partnership Agreement (to MCS, including project PTDC/MED-PAT/30385/2017, iNOVA4Health-UIDB/04462/2020, research infrastructure PPBI-POCI-01-0145-FEDER-022122, M-ERA.NET 2/0005/2016), Boehringer Ingelheim (to MCS), Fight for Sight UK (to MCS), Wellcome Trust grant number 212216/Z/18/Z/ (to CEF). MJH was funded by Moor-fields Eye Charity with the Bill Brown 1989 Charitable Trust PhD studentship 538158, MLS was funded by FCT-CEECIND/01536/2018, ACF was funded by FCT PhD studentship (PD/BD/135503/2018). This work was developed with the support from the research infrastructure PPBI-POCI-01-0145-FEDER-022122, co-financed by FCT (Portugal) and Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund) and this article is supported by the LYSOCIL project funded by the European Union{\textquoteright}s Horizon 2020 programme under grant agreement No. 811087. Publisher Copyright: Copyright 2021 The Authors",
year = "2021",
month = jul,
doi = "10.1167/iovs.62.9.39",
language = "English",
volume = "62",
journal = "Investigative ophthalmology & visual science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology",
number = "9",
}